Marikki Laiho

11.0k total citations · 2 hit papers
116 papers, 9.2k citations indexed

About

Marikki Laiho is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Marikki Laiho has authored 116 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Molecular Biology, 41 papers in Oncology and 28 papers in Cancer Research. Recurrent topics in Marikki Laiho's work include Cancer-related Molecular Pathways (31 papers), RNA modifications and cancer (22 papers) and TGF-β signaling in diseases (18 papers). Marikki Laiho is often cited by papers focused on Cancer-related Molecular Pathways (31 papers), RNA modifications and cancer (22 papers) and TGF-β signaling in diseases (18 papers). Marikki Laiho collaborates with scholars based in Finland, United States and Sweden. Marikki Laiho's co-authors include Joan Massagué, Jorma Keski‐Oja, Leena Latonen, Olli Saksela, Alejandro Zentella‐Dehesa, Xiao-Fan Wang, Liliana Attisano, Jacqueline Doody, Jeffrey L. Wrana and Juan M. Cárcamo and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Marikki Laiho

116 papers receiving 9.1k citations

Hit Papers

TGFβ signals through a he... 1990 2026 2002 2014 1992 1990 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. TGFβ signals through a heteromeric protein kinase receptor complex
    1992 1.3k citations Marikki Laiho, Joan Massagué et al. Cell profile →
  2. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation
    1990 710 citations Marikki Laiho, James A. DeCaprio et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marikki Laiho Finland 42 6.8k 2.8k 1.7k 931 638 116 9.2k
Herbert A. Weich Germany 52 7.7k 1.1× 3.2k 1.1× 2.9k 1.7× 847 0.9× 736 1.2× 114 11.9k
Shafaat A. Rabbani Canada 50 3.9k 0.6× 2.5k 0.9× 2.2k 1.3× 628 0.7× 378 0.6× 136 6.7k
Xosé S. Puente Spain 40 3.2k 0.5× 1.7k 0.6× 2.3k 1.4× 918 1.0× 444 0.7× 80 6.5k
Mark D. Sternlicht United States 27 3.0k 0.4× 3.0k 1.1× 3.0k 1.8× 788 0.8× 651 1.0× 45 7.2k
William P. Schiemann United States 59 6.8k 1.0× 3.5k 1.3× 2.4k 1.5× 1.0k 1.1× 924 1.4× 132 11.1k
Katia Manova United States 47 7.4k 1.1× 1.9k 0.7× 1.6k 1.0× 516 0.6× 973 1.5× 79 10.7k
Antonio Postigo Spain 40 5.0k 0.7× 2.8k 1.0× 1.2k 0.7× 586 0.6× 716 1.1× 74 7.7k
Carole Perruzzi United States 27 4.8k 0.7× 1.3k 0.5× 1.6k 1.0× 931 1.0× 540 0.8× 31 7.9k
Leslie I. Gold United States 50 4.3k 0.6× 1.9k 0.7× 1.1k 0.7× 1.1k 1.1× 1.0k 1.6× 105 8.6k
Edward B. Leof United States 46 4.1k 0.6× 1.5k 0.5× 749 0.5× 645 0.7× 899 1.4× 106 7.3k

Countries citing papers authored by Marikki Laiho

Since Specialization
Citations

This map shows the geographic impact of Marikki Laiho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marikki Laiho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marikki Laiho more than expected).

Fields of papers citing papers by Marikki Laiho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marikki Laiho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marikki Laiho. The network helps show where Marikki Laiho may publish in the future.

Co-authorship network of co-authors of Marikki Laiho

This figure shows the co-authorship network connecting the top 25 collaborators of Marikki Laiho. A scholar is included among the top collaborators of Marikki Laiho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marikki Laiho. Marikki Laiho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Weiliang, Maureen A. Kane, Marikki Laiho, et al.. (2024). Deep PIM kinase substrate profiling reveals new rational cotherapeutic strategies for acute myeloid leukemia. Blood Advances. 8(15). 3880–3892. 1 indexed citations
2.
Sengupta, Srona, Liang Zhao, Matthew L. Arwood, et al.. (2022). Persistent CAD activity in memory CD8 + T cells supports rRNA synthesis and ribosomal biogenesis required at rechallenge. Science Immunology. 7(71). eabh4271–eabh4271. 13 indexed citations
3.
Low, Jin‐Yih, W. Nathaniel Brennen, Alan K. Meeker, et al.. (2020). Stromal CAVIN1 Controls Prostate Cancer Microenvironment and Metastasis by Modulating Lipid Distribution and Inflammatory Signaling. Molecular Cancer Research. 18(9). 1414–1426. 18 indexed citations
4.
Hämäläinen, Riikka H., Kati J. Ahlqvist, Steffi Goffart, et al.. (2019). Defects in mtDNA replication challenge nuclear genome stability through nucleotide depletion and provide a unifying mechanism for mouse progerias. Nature Metabolism. 1(10). 958–965. 57 indexed citations
5.
Güner, Güneş, Paul Sirajuddin, Qizhi Zheng, et al.. (2017). Novel Assay to Detect RNA Polymerase I Activity In Vivo. Molecular Cancer Research. 15(5). 577–584. 12 indexed citations
6.
Peltonen, Karita, Laureen Colis, Hester Liu, et al.. (2014). Small Molecule BMH-Compounds That Inhibit RNA Polymerase I and Cause Nucleolar Stress. Molecular Cancer Therapeutics. 13(11). 2537–2546. 66 indexed citations
7.
Bai, Baoyan, Srinivasan Yegnasubramanian, Sarah J. Wheelan, & Marikki Laiho. (2014). RNA-Seq of the Nucleolus Reveals Abundant SNORD44-Derived Small RNAs. PLoS ONE. 9(9). e107519–e107519. 21 indexed citations
8.
Ni, Xiaohua, Yonggang Zhang, Judit Ribas, et al.. (2011). Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts. Journal of Clinical Investigation. 121(6). 2383–2390. 119 indexed citations
9.
Moore, Henna M., Baoyan Bai, François‐Michel Boisvert, et al.. (2011). Quantitative Proteomics and Dynamic Imaging of the Nucleolus Reveal Distinct Responses to UV and Ionizing Radiation. Molecular & Cellular Proteomics. 10(10). M111.009241–M111.009241. 107 indexed citations
10.
Band, Arja M. & Marikki Laiho. (2011). Crosstalk of TGF-β and Estrogen Receptor Signaling in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. 16(2). 109–115. 77 indexed citations
11.
Jäämaa, Sari, Taija M. af Hällström, Anna Sankila, et al.. (2010). DNA Damage Recognition via Activated ATM and p53 Pathway in Nonproliferating Human Prostate Tissue. Cancer Research. 70(21). 8630–8641. 49 indexed citations
12.
Peltonen, Karita, Laureen Colis, Hester Liu, et al.. (2010). Identification of Novel p53 Pathway Activating Small-Molecule Compounds Reveals Unexpected Similarities with Known Therapeutic Agents. PLoS ONE. 5(9). e12996–e12996. 79 indexed citations
13.
Willebrand, Maria von, et al.. (2005). FGF‐2 blocks TGF‐β1‐mediated suppression of Bcl‐2 in normal melanocytes. Experimental Dermatology. 14(3). 202–208. 9 indexed citations
14.
Latonen, Leena & Marikki Laiho. (2005). Cellular UV damage responses—Functions of tumor suppressor p53. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1755(2). 71–89. 164 indexed citations
15.
Laiho, Marikki & Leena Latonen. (2003). Cell cycle control, DNA damage checkpoints and cancer. Annals of Medicine. 35(6). 391–397. 36 indexed citations
16.
Latonen, Leena, Sari Kurki, Kimmo Pitkänen, & Marikki Laiho. (2003). p53 and MDM2 are regulated by PI-3-kinases on multiple levels under stress induced by UV radiation and proteasome dysfunction. Cellular Signalling. 15(1). 95–102. 32 indexed citations
17.
18.
Pitkänen, Kimmo, et al.. (1997). p53 Transactivation and Protein Accumulation Are Independently Regulated by UV Light in Different Phases of the Cell Cycle. Molecular and Cellular Biology. 17(6). 3074–3080. 32 indexed citations
19.
Saksela, Olli & Marikki Laiho. (1990). [Growth factors and the extracellular matrix].. PubMed. 106(3). 297–306. 1 indexed citations
20.
Laiho, Marikki, James A. DeCaprio, John W. Ludlow, David M. Livingston, & Joan Massagué. (1990). Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell. 62(1). 175–185. 710 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Herbert A. Weich Breakdown of academic impact, for papers by Shafaat A. Rabbani Breakdown of academic impact, for papers by Xosé S. Puente Breakdown of academic impact, for papers by Mark D. Sternlicht Breakdown of academic impact, for papers by William P. Schiemann Breakdown of academic impact, for papers by Katia Manova Breakdown of academic impact, for papers by Antonio Postigo Breakdown of academic impact, for papers by Carole Perruzzi Breakdown of academic impact, for papers by Leslie I. Gold Breakdown of academic impact, for papers by Edward B. Leof
Rankless by CCL
2026